Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease (Vaccines, 2024)

(untitled) - Woelfel, S; Dütschler, J; Junker, D; König, M; Leinenkugel, G; Graf, N; Krieger, C; Truniger, S; Franke, A; Koller, S; Metzger-Peter, K; Oberholzer, M; et al.